Uploaded May 2026 | Updated September 2026, 2 weeks ago
Morgan Keefer is a Board Member for the Institute of Cannabis Science, and an experienced cannabis testing laboratory accreditation professional. She has presented at conferences, including CannMed, Pittcon, and Cannabis Science Conference regarding the importance of inter-laboratory comparison and method validation for the cannabis industry.
At CannMed 26, Morgan will present Frequently Identified Nonconformances Applicable to Cannabis Testing, which will explore some of the challeges that come with operating a cannabis lab as well as opportunities for improvement.
During our conversation we discuss:
- Cannabis labs must be ISO/IEC 17025 accredited to prove they are competent to test for potency, contaminants, and other critical safety markers that protect consumers.
- Inconsistent state regulations and federal illegality create unique challenges for cannabis labs, including the need to rapidly validate new test methods as rules change.
- Sample manipulation by producers (i.e., bleaching samples or inflating potency) is a real problem that undermines lab results and puts consumers at risk.
- Many labs fall short on method validation and measurement uncertainty, sometimes reporting results for years without fully validating their methods across all product types.
- Consumers can protect themselves by requesting certificates of analysis, asking labs to confirm their results directly, and watching for measurement uncertainty disclosures — especially for hemp products where fake COAs are increasingly common.
Thanks to This Episode’s Sponsor: CANN
Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org.
Additional Resources
Institute of Cannabis Science Tip Line - tipline@cannsci.org
Coalition for Cannabis Worker Safety - Cannabisworkersafety@gmail.com
Register for CannMed 26 - cannmedevents.com/package-options
Meet the CannMed 26 Speakers - cannmedevents.com/speakers
Review the Podcast - podcasts.apple.com/us/podcast/cannmed-coffee-talk/id1504218804
CannMed Archive - cannmedevents.com/cannmed-video-archives
Morgan Keefer is a Board Member for the Institute of Cannabis Science, and an experienced cannabis testing laboratory accreditation professional. She has presented at conferences, including CannMed, Pittcon, and Cannabis Science Conference regarding the importance of inter-laboratory comparison and method validation for the cannabis industry.
At CannMed 26, Morgan will present Frequently Identified Nonconformances Applicable to Cannabis Testing, which will explore some of the challeges that come with operating a cannabis lab as well as opportunities for improvement.
During our conversation we discuss:
- Cannabis labs must be ISO/IEC 17025 accredited to prove they are competent to test for potency, contaminants, and other critical safety markers that protect consumers.
- Inconsistent state regulations and federal illegality create unique challenges for cannabis labs, including the need to rapidly validate new test methods as rules change.
- Sample manipulation by producers (i.e., bleaching samples or inflating potency) is a real problem that undermines lab results and puts consumers at risk.
- Many labs fall short on method validation and measurement uncertainty, sometimes reporting results for years without fully validating their methods across all product types.
- Consumers can protect themselves by requesting certificates of analysis, asking labs to confirm their results directly, and watching for measurement uncertainty disclosures — especially for hemp products where fake COAs are increasingly common.
Thanks to This Episode’s Sponsor: CANN
Since 2015, CANN has been building a strong network of scientists in the cannabis space to promote scientific innovation, safety, and development through education, research, and the empowerment of the scientific community. To learn more about what CANN has to offer please visit their website at www.cann-acs.org.
Additional Resources
Institute of Cannabis Science Tip Line - tipline@cannsci.org
Coalition for Cannabis Worker Safety - Cannabisworkersafety@gmail.com
Register for CannMed 26 - cannmedevents.com/package-options
Meet the CannMed 26 Speakers - cannmedevents.com/speakers
Review the Podcast - podcasts.apple.com/us/podcast/cannmed-coffee-talk/id1504218804
CannMed Archive - cannmedevents.com/cannmed-video-archives
![Breeding for Better Solventless Extraction with Alisha Holloway, PhD
Alisha Holloway is the Chief Scientific Officer at Phylos where she leads the R&D group that focuses on foundational genomic research, development of high-throughput genetic and chemical testing capabilities, discovery of genetic markers, and the development of new cannabis varieties via classical and marker-assisted breeding.
At CannMed 26, she will present “Enhancing Cannabis Quality via Marker-Assisted Selection for Improved Solventless Extraction Yield”
During our conversation, we discuss:
* What solventless extraction is and why its gaining popularity
* The traits that make a cannabis plant a good washer
* How Alisha’s team designed and conducted a washability study across hundreds of plant samples
* How they identified genetic markers for good washers that hold up across diverse genetic backgrounds
* How marker-assisted selection accelerates the breeding process
Thanks to This Episodes Sponsor: The Cannabis Research Center & Coalition.
The Cannabis Research Center & Coalition (CRC), founded by Dr. Allison Justice, is a professional group dedicated to advancing cannabis cultivation and post harvest processing. CRC partners with Universities and The Hemp Mine LLC, an industry leader in cannabis genetics and production, to tackle the cultivation and post harvest challenges facing today’s cannabis industry.
Their cooperative research model, inspired by successful horticulture and greenhouse research collaborations, allows members to benefit from pooled resources, gaining access to cutting-edge, science-based research at a fraction of the cost.
Learn more at cannabisrc.org
Additional Resources
* Phylos - https://phylos.bio/
* Instagram - https://www.instagram.com/phylosbio/
* Linkedin - https://www.linkedin.com/company/phylosbio
* [Blog] What Makes a Cannabis Variety “Wash Well”? The Science Behind High-Yield Hash Plants - https://phylos.bio/blog/cannabis-washability-genetics
* https://www.instagram.com/shwale/
* Register for CannMed 26 - https://cannmedevents.com/package-options/
* Meet the CannMed 26 Speakers - https://cannmedevents.com/speakers/
* Review the Podcast - https://podcasts.apple.com/us/podcast/cannmed-coffee-talk/id1504218804
* CannMed Archive - https://cannmedevents.com/cannmed-video-archives/ Breeding for Better Solventless Extraction with Alisha Holloway, PhD](https://i.ytimg.com/vi/yTmycWnOfHE/mqdefault.jpg)
![What is Cannabinoid Hyperemesis Syndrome & Why Has Researching it been so difficult? - Codi Peterson
Dr. Codi Peterson is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Radys Childrens Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.
He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”.
During our conversation, we discuss:
- Defining CHS and explaining why it is difficult to research
- Cannabis use patterns among CHS sufferers
- Whether contaminants and pesticides play a role in developing CHS
- The prodromal phase and early warning signs of CHS
- Sex-based differences in CHS patients
- Understanding the biological mechanisms behind the development of CHS
- and more
Thanks to This Episodes Sponsor: The Cannigma
The Cannigma takes an evidence-based approach to cannabis content – from safety to cooking to medical research – and makes all the information digestible and useful.
They are committed to making sure scientific information is accessible to anyone who needs it – be it to relieve their own suffering or that of a loved one, to learn a bit more, or even just for fun.
Learn more at cannigma.com
Additional Resources
- Surveying Cannabinoid Hyperemesis Syndrome Patients with Megan Mbengue and Codi Peterson [Video] - https://youtu.be/ez7PyEESrSU
- Cannabinoid Hyperemesis Syndrome What You Need to Know [Video] - https://youtu.be/9hCp6puJvXc?si=Gc14ELLhC3S5KOBL
- what-is-chs.com
- Codi on IG - https://www.instagram.com/cannabispharmd/
- Codi on LinkedIn - https://www.linkedin.com/in/cannapharmd/
- The Cannigma - cannigma.com
- Register for CannMed 26 - Early Bird Ends February 20th! - https://cannmedevents.com/package-options/ What is Cannabinoid Hyperemesis Syndrome & Why Has Researching it been so difficult? - Codi Peterson](https://i.ytimg.com/vi/ykNUSCa1d14/mqdefault.jpg)


